Literature DB >> 22564865

Age-dependent increase of memory B cell response to cytomegalovirus in healthy adults.

Judith H Aberle1, Elisabeth Puchhammer-Stöckl.   

Abstract

Human cytomegalovirus (HCMV) may play an important role in immune system aging, due to its ability to modulate the host immune system. A significant age-related increase has been demonstrated for HCMV-specific serum antibody levels but so far, no information exists whether and to which extent the magnitude of the HCMV-specific memory B cell response develops with increasing age. We examined the size of the HCMV-specific memory B cell response and assessed whether there are quantitative differences in HCMV-specific memory B cell numbers and serum antibody titers against HCMV in young and older persons. The quantities of HCMV-specific memory B cells were determined in 20 young (20-31 years) and 21 older (60-80 years) healthy volunteers by limiting dilution analysis. HCMV-specific antibody levels were analyzed by ELISA. Our study demonstrates that higher HCMV-specific plasma antibody levels correlated well with the numbers of circulating HCMV-specific memory B cells and were not due to a generally higher antibody production in these individuals. The magnitude of HCMV-specific memory B cell responses was significantly higher in the group of older as compared to young subjects, but showed a high degree of individual variation in elderly persons. Together, the results of the present study indicate that the circulating memory B cell pool against HCMV increases during aging in humans. The expansion of HCMV-specific memory B cells and antibody titers possibly contribute to the sustained control of HCMV infection during old age.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22564865     DOI: 10.1016/j.exger.2012.04.008

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  9 in total

1.  T cell-dependent IgM memory B cells generated during bacterial infection are required for IgG responses to antigen challenge.

Authors:  Jennifer L Yates; Rachael Racine; Kevin M McBride; Gary M Winslow
Journal:  J Immunol       Date:  2013-06-26       Impact factor: 5.422

Review 2.  Aging and neoteny in the B lineage.

Authors:  Doron Melamed; David W Scott
Journal:  Blood       Date:  2012-08-30       Impact factor: 22.113

3.  Cytomegalovirus antibody levels and mortality among hospitalised elderly patients.

Authors:  Santiago González-Quijada; Mikel Del Álamo-Martínez de Lagos; Marina Álvarez-Llabrés; Lorena Pérez-González
Journal:  Ann Med       Date:  2020-08-24       Impact factor: 4.709

4.  TTV DNA plasma load and its association with age, gender, and HCMV IgG serostatus in healthy adults.

Authors:  Mats Haloschan; Rainer Bettesch; Irene Görzer; Lukas Weseslindtner; Michael Kundi; Elisabeth Puchhammer-Stöckl
Journal:  Age (Dordr)       Date:  2014-10-05

5.  Infectious reactivation of cytomegalovirus explaining age- and sex-specific patterns of seroprevalence.

Authors:  Michiel van Boven; Jan van de Kassteele; Marjolein J Korndewal; Christiaan H van Dorp; Mirjam Kretzschmar; Fiona van der Klis; Hester E de Melker; Ann C Vossen; Debbie van Baarle
Journal:  PLoS Comput Biol       Date:  2017-09-26       Impact factor: 4.475

6.  Antibodies to Human Herpesviruses and Rate of Incident Cardiovascular Events and All-Cause Mortality in the UK Biobank Infectious Disease Pilot Study.

Authors:  Petrina Chu; Sharon Louise Cadogan; Charlotte Warren-Gash
Journal:  Open Forum Infect Dis       Date:  2022-06-11       Impact factor: 4.423

7.  Seropositivity and higher immunoglobulin g antibody levels against cytomegalovirus are associated with mortality in the population-based European prospective investigation of Cancer-Norfolk cohort.

Authors:  Effrossyni Gkrania-Klotsas; Claudia Langenberg; Stephen J Sharp; Robert Luben; Kay-Tee Khaw; Nicholas J Wareham
Journal:  Clin Infect Dis       Date:  2013-02-26       Impact factor: 9.079

8.  Frequency and phenotype of B cell subpopulations in young and aged HIV-1 infected patients receiving ART.

Authors:  Sylvie Amu; Gitit Lavy-Shahaf; Alberto Cagigi; Bo Hejdeman; Silvia Nozza; Lucia Lopalco; Ramit Mehr; Francesca Chiodi
Journal:  Retrovirology       Date:  2014-09-11       Impact factor: 4.602

Review 9.  Primary vaccine failure to routine vaccines: Why and what to do?

Authors:  Ursula Wiedermann; Erika Garner-Spitzer; Angelika Wagner
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.